Trial Profile
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 01 Jul 2016 Status changed from active, no longer recruiting to withdrawn prior to enrolment as principal investigator left institution.
- 08 Dec 2015 New trial record